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ABSTRACT
Sarcomatoid carcinoma is a rare malignant tumor of unknown pathogenesis
characterized by poorly differentiated carcinoma tissue containing sarcoma-like
differentiation of either spindle or giant cell and rarely occurs in the gastrointestinal
tract and hepatobiliary-pancreatic system.1 Primary hepatic sarcomatoid carcinoma
accounts for only 0.2 % of primary malignant liver tumors, and 1.8% of all surgically
resected hepatocellular carcinomas.2 The majority of hepatic sarcomatoid carcinoma
cases appear to occur simultaneously with hepatocellular or cholangiocellular
carcinoma.3 The preferred treatment for hepatic sarcomatoid carcinoma is surgical
resection and the overall prognosis is poor.4 This case depicts a 62-year-old female who
underwent initial resection of a cavernous hemangioma in 2010. Seven years after
her initial diagnosis, she developed what was initially felt to be local recurrence of the
hemangioma but additional diagnostic workup with a liver biopsy confirmed primary
hepatic sarcomatoid carcinoma.
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A 62-year-old female with past medical history
significant for vegan diet, hypothyroidism, iron
deficiency anemia, and cavernous liver hemangioma
presented with weight loss and abdominal fullness
for approximately one month with two days of acute
altered mental status, fatigue, and weakness.
Patient had a complicated gastrointestinal history
and underwent surgical resection of a cavernous
hemangioma in 2010. Six years later, she developed
abdominal fullness with right upper quadrant pain
and an abdominal ultrasound at that time suggested
hemangioma recurrence. In 2017, she underwent
laparoscopy with unroofing of the hemangioma,
drainage of an old organizing hematoma, removal of
debris, and placement of an omental patch. Patient
developed subsequent abdominal ventral hernia but
a scheduled repair in January of 2018 was deferred
due new onset of iron deficiency anemia with a
hemoglobin of 6.7 g/dL. She underwent EGD and
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colonoscopy which revealed candida esophagitis and
diverticulosis but no identifiable bleeding source.
Her acute anemia was attributed to a nutritional
deficit from her vegan diet so ferrous sulfate 325 mg
tablets three times a day were started. Abdominal
CT scan showed a 13.6 cm mass adjacent to the
gallbladder fossa, but further workup was deferred
due to her anemia. In February, the patient’s anemia
persisted despite oral iron replacement therapy
and she received infusion of feraheme 510 mg. She
underwent subsequent EGD for reevaluation of
anemia and repair of periumbilical hernia during
the same month. In March, she was admitted for
abnormal PET scan concerning for liver malignancy
with maximum SUV of 20.1 g/mL. Liver abscess was
diagnosed and CT guided drainage was performed.
She was treated with amoxicillin/clavulanate and
discharged home.
Three weeks later, she returned with abdominal
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pain, fatigue, poor appetite, intermittent fevers,
altered mental status, and diarrhea. On examination,
patient appeared uncomfortable, pale, and weak.
Her medications included armour thyroid, ranitidine,
and amoxicillin/clavulanate. Vitals included: pulse
rate 127, blood pressure 108/56, temperature 101.8,
respiratory rate 20 and oxygen saturations of 98 % on
room air. Patient appeared drowsy but cooperative
and not in distress. HEENT: normocephalic, pupils
equal, round and reactive to light, extraocular
movement intact. Respiratory: tachypneic with nonlabored respirations and decreased breath sounds
bilaterally. Cardiovacular: tachycardic with normal
rhythm. Gastrointestinal: soft, non-tender, nondistended, normal bowel sounds. Surgical incision
sites were healing. Skin: warm, dry, pink with +2
pitting bilateral lower extremity edema.
Diagnostic data demonstrated leukocytosis of 15 g/
dL, hemoglobin of 6.0 g/dL, albumin of 1.5 g/dL, and
normal liver enzymes with mildly elevated bilirubin
level of 1.2 mg/dL. CT scan of abdomen showed large
heterogeneous lobular mass measuring 14.6 cm x
10.8 cm in the superior portion of the right liver lobe
with an inferior calcified cystic mass measuring 6.5
cm x 5.3 cm. Acute hepatitis panel, serum alpha-feto
protein, carcinomembryonic antigen, and CA-19-9

were negative. Patient started on vancomycin and
piperacillin/tazobactam, and transfused two units of
PRBCs. Gastrointestinal PCR panel was positive for
enteropathic Escherichia coli and Clostridium difficile
so oral vancomycin was initiated. Additional anemia
workup including bone marrow biopsy, EGD, and
tagged RBC scan did not reveal source of anemia. CT
enterography (Figure 1) showed large liver mass with
liquefaction and air in inferior portion and a small
tract of fluid between the mass and duodenal bulb
concerning for fistulous tract.
Diagnosis of hepatic sarcomatoid carcinoma was
obtained by liver biopsy with gross specimen
demonstrating spindle shaped cells (Figures
2-4).1,5,6,7 Immunohistochemical panel additionally
confirmed sarcomatoid carcinoma given expression
of multiple cytokeratin (CAM 5.2, cytokeratin AE1/
AE3, oscar cytokeratin) and lack of reactivity for
other lineage specific markers (Melan-A and SOX10,
SMA, ALK, ERG, Desmin, CD21, CD3, CD20, CD15,
CD30, PAX5, CD45, CD5, and S100). Sarcomatoid
hepatocellular carcinoma and cholangiocarcinoma
with sarcomatoid features were excluded as
immunohistochemistry testing was negative for
Hep Par-1, Arginase, Albumin ISH. The patient was
transferred to a liver center and ultimately pursued

FIGURE 1: Large liver mass
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FIGURE 2: Low-power view predominantly showing a diffuse area of tumor with
an area of benign liver with steatosis on the right side corner

A

B

FIGURE 3: A) Low-power view showing spindle growth pattern of tumor, B) Highpower view showing spindle neoplastic cells with large cells

FIGURE 4: Immunohistochemical stains for multiple cytokeratins are positive for tumor
– A) Oscar cytokeratin, B) CAMP5.2, and C) Pancytokeratin (AE1/AE3).
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hospice due to poor prognosis and passed away a
few weeks later.
DISCUSSION
Hepatic sarcomatoid carcinoma is a rare malignant
neoplasm of unclear pathogenesis. Presenting
symptoms of sarcomatoid carcinoma are similar to
that of hepatoceullar carcinoma with abdominal
pain, weight loss, anorexia, and fatigue, which
was the case for our patient. Hepatic sarcomatoid
has a high risk of relapse, venous and intrahepatic
invasion, and distant and lymph node metastasis
at time of diagnosis. The preferred treatment for
hepatic sarcomatoid carcinoma is surgical resection
and the overall prognosis is poor.8
The present study reports a rare case of hepatic
sarcomatoid carcionoma in a patient with a
previous cavernous hemangioma. Previous studies
have reported the usefulness of chemotherapy
and literature review found one study with
documentation of complete resolution of hepatic
sarcomatoid carcinoma after seven cycles of
doxorubicin and ifosfamide but no large-sample
studies exist.9 Efficacy of alternative treatments
such as radiotherapy, chemotherapy, and targeted
therapy are unclear.
Liver conditions that have been associated with
the development of liver sarcomatoid carcinoma
include hepatitis C virus (HCV) and hepatocellular
carcinoma (HCC).10 Though liver malignancy can also
be secondary to a primary GI sarcoma it is a rare or
unknown cause of liver sarcomatoid carcinoma. In
this particular case, the patient did not have a history
of HCV, HCC or gastrointestinal malignancy. Her
presentation was confounded by a history of iron
deficiency anemia, and development of a hepatic
abscess after surgical intervention to un-roof a
recurring cyst which turned out to be hematoma.
Cystic lesions of the liver are a common occurrence
but rarely lead to primary liver neoplasms. The
diagnosis of hepatic sarcomatoid remains elusive
due its vague symptomatology and rarity. Additional
studies are needed to explore possible adjunctive
therapies to surgical resection to improve survival
rates.
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